Case Report: Combination of Olaparib With Chemotherapy in a Patient With ATM-Deficient Colorectal Cancer

Poly-ADP ribose polymerase (PARP) inhibitors are constantly increasing in their indications for use as anti-cancer treatment in various neoplasms, the majority of which are linked with BRCA deficiency. Preclinical data support the investigation of PARP inhibitors in other neoplasms exhibiting “BRCAn...

Descripción completa

Detalles Bibliográficos
Autores principales: Papageorgiou, Georgios I., Fergadis, Evangelos, Skouteris, Nikos, Christakos, Evridiki, Tsakatikas, Sergios A., Lianos, Evangelos, Kosmas, Christos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728007/
https://www.ncbi.nlm.nih.gov/pubmed/35004311
http://dx.doi.org/10.3389/fonc.2021.788809

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728007/
https://www.ncbi.nlm.nih.gov/pubmed/35004311
http://dx.doi.org/10.3389/fonc.2021.788809

Ejemplares similares